Study of the Prothrombin Gene 20201 GA Variant in FV:Q 506 Carriers in Relationship to the Presence or Absence of Juvenile Venous Thromboembolism
- 1 February 1999
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 19 (2), 276-280
- https://doi.org/10.1161/01.atv.19.2.276
Abstract
—The G20210A transition of the prothrombin gene has been identified as a common but probably mild hereditary risk factor for venous thromboembolism (VTE). However, the prothrombin gene variant might contribute to the penetrance of thromboembolic disease in many patients with other prothrombotic defects, such as the FV:R506Q mutation. In this investigation, the A20210 allele was found in 9 of 450 healthy controls (2%). Among 89 asymptomatic FV:Q 506 carriers, 3 subjects were doubly affected (3.4%). In contrast, of 263 unrelated carriers of the FV:Q 506 mutant with a history of juvenile VTE, 30 also had the prothrombin gene G20210A variant (11.4%), including 25 of 220 patients who were heterozygous (11.4%) and 5 of 43 homozygous (11.6%) for FV:Q 506 . Thus, the A20210 allele of the prothrombin gene is significantly overrepresented in symptomatic FV:Q 506 carriers compared with healthy controls ( P P =0.02). Persons homozygous for the 20210A allele were not found. A statistically significant increase in the prevalence of more unusual sites of venous thrombosis at clinical onset was found in doubly affected patients (9 of 30; 30%) compared with patients without the prothrombin gene variant (26 of 233; 11.1%) ( P =0.004). First VTE occurred spontaneously in 53.3% of all doubly affected patients (16 of 30) and in 28.3% of all simply affected patients (66 of 233) ( P =0.005). Among patients with VTE preceded by circumstantial risk factors, the A20210 allele was found in 7.7% (14 of 181). We conclude that the A20210 allele of the prothrombin gene is frequently coinherited in symptomatic FV:Q 506 carriers and possibly influences age, site, and type of thrombotic onset manifestation in these patients.Keywords
This publication has 18 references indexed in Scilit:
- Resistance to activated protein C (APCR) in children with venous or arterial thromboembolismBritish Journal of Haematology, 1996
- Population differences in the frequency of the factor V Leiden variant among people with clinically symptomatic protein C deficiency.Journal of Medical Genetics, 1995
- An allosteric switch controls the procoagulant and anticoagulant activities of thrombin.Proceedings of the National Academy of Sciences of the United States of America, 1995
- Mutation in the Gene Coding for Coagulation Factor V and the Risk of Myocardial Infarction, Stroke, and Venous Thrombosis in Apparently Healthy MenNew England Journal of Medicine, 1995
- Mutation in blood coagulation factor V associated with resistance to activated protein CNature, 1994
- Resistance to Activated Protein C as a Basis for Venous ThrombosisNew England Journal of Medicine, 1994
- Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden Thrombophilia StudyThe Lancet, 1993
- Inherited predisposition to thrombosisCell, 1993
- Thrombin, a Link between Coagulation Activation and FibrinolysisAnnals of the New York Academy of Sciences, 1992
- Nucleotide sequence of the gene for human prothrombinBiochemistry, 1987